Guardian Pharmacy Services Hits New 52-Week High at $42.00

Guardian Pharmacy Services, Inc. has reached a significant milestone by hitting a new 52-week high of USD 42.00 on June 9, 2026. This achievement highlights the company's strong performance within the retailing industry, particularly as it navigates the competitive landscape of small-cap stocks. Over the past year, Guardian Pharmacy Services has demonstrated a robust performance, with a notable increase of 22.99% compared to the S&P 500. The company's market capitalization stands at USD 2,163 million, reflecting its position as a small-cap player in the market. In terms of financial metrics, Guardian Pharmacy Services has a price-to-earnings (P/E) ratio of 41.00, indicating investor expectations for future growth. However, the company currently does not offer a dividend yield, and its debt-to-equity ratio is reported at -0.27, suggesting a unique capital structure. As Guardian Pharmacy Services continues to make strides in the retailing sector, its recent price achievement underscores its current market position and performance indicators.